Hudson N, Brydon W G, Eastwood M A, Ferguson A, Palmer K R
Gastrointestinal Unit, Western General Hospital, Edinburgh, UK.
Aliment Pharmacol Ther. 1995 Feb;9(1):47-50. doi: 10.1111/j.1365-2036.1995.tb00350.x.
The optimum regimen for the eradication of Helicobacter pylori remains unclear. The aim of this study was to determine the efficacy and tolerability of omeprazole 40 mg daily given for 2 weeks, plus amoxycillin 500 mg t.d.s. and metronidazole 400 mg t.d.s. given for the first 7 days, in the treatment of H. pylori associated peptic ulcer disease.
One hundred and thirty-two consecutive patients with peptic ulcer disease were entered into the study (89 male, 41 female; median age 47 years; inter-quartile range: 36-58 years). H. pylori was eradicated successfully in 109 of 130 patients (intention-to-treat: 83%; 95% confidence limits: 76-89%); per protocol: 85% (95% CI: 78-91%)). Ninety per cent of patients completed the full course of therapy. Only four patients (3%) stopped treatment as a result of side effects although these occurred in 41% of patients. One patient developed pseudomembranous colitis requiring hospital admission.
Omeprazole combined with one week of treatment of amoxycillin and metronidazole is an effective and well tolerated Helicobacter eradication regimen. Occasional severe side effects remain a risk, even when the duration of antibiotic exposure is reduced.
根除幽门螺杆菌的最佳方案仍不明确。本研究的目的是确定每日服用40毫克奥美拉唑,疗程为2周,加在前7天每日三次每次服用500毫克阿莫西林和每日三次每次服用400毫克甲硝唑,用于治疗幽门螺杆菌相关性消化性溃疡疾病的疗效和耐受性。
132例连续性消化性溃疡疾病患者进入本研究(男性89例,女性41例;年龄中位数47岁;四分位间距:36 - 58岁)。130例患者中有109例幽门螺杆菌被成功根除(意向性治疗:83%;95%置信区间:76 - 89%);符合方案分析:85%(95%可信区间:78 - 91%)。90%的患者完成了整个疗程。仅有4例患者(3%)因副作用停止治疗,尽管41%的患者出现了副作用。1例患者发生假膜性结肠炎,需要住院治疗。
奥美拉唑联合一周的阿莫西林和甲硝唑治疗是一种有效且耐受性良好的根除幽门螺杆菌方案。即使减少抗生素暴露时间,偶尔仍有严重副作用的风险。